Alkermes plc

ALKS ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $388.6M $291.1M $457.5M $292.5M $337.5M $273.0M $203.8M $266.8M
Accounts Receivable $334.0M $384.5M $332.5M $288.0M $313.2M $275.1M $257.1M $292.2M
Inventory $196.6M $182.9M $186.4M $181.4M $150.3M $125.7M $101.8M $90.2M
Total Current Assets $1.93B $1.42B $1.49B $1.13B $1.06B $1.11B $962.0M $983.3M
Property, Plant & Equipment $221.7M $227.6M $226.9M $222.9M $341.1M $350.0M $362.2M $310.0M
Goodwill $83.0M $83.0M $83.0M $83.0M $92.9M $92.9M $92.9M $92.9M
Intangible Assets (Excl. Goodwill) $815.0K $890.0K $2.0M $37.7M $74.0M $111.2M $150.6M $191.0M
Total Assets $2.49B $2.06B $2.14B $1.96B $2.02B $1.95B $1.81B $1.83B
Liabilities
Accounts Payable $108.0M $45.6M $65.6M $32.8M $55.7M $46.0M $54.3M $39.8M
Total Current Liabilities $543.4M $465.2M $520.2M $497.7M $471.3M $438.3M $391.1M $339.8M
Long-Term Debt — — $287.7M $290.3M $292.8M $272.1M $274.3M $276.5M
Total Liabilities $667.7M $590.6M $933.5M $920.2M $911.9M $882.7M $720.0M $653.7M
Stockholders' Equity
Retained Earnings $-734.8M $-976.5M $-1.34B $-1.70B $-1.54B $-1.49B $-1.38B $-1.19B
Total Stockholders' Equity $1.82B $1.46B $1.20B $1.04B $1.11B $1.07B $1.09B $1.17B
← Newer Page 1 of 2 Older →